3rd Annual Cholangiocarcinoma Foundation Poster Abstract Awards

Three winners awarded for making significant contributions to research for rare cancer known as cholangiocarcinoma

The Cholangiocarcinoma Foundation announced the 2023 Poster Abstract Awards at its annual conference that took place virtually and in person in Salt Lake City April 12-14.

The Foundation had 62 abstracts submitted with three selected for oral poster presentations. All posters were reviewed by the Abstract Review Committee Chaired by Chiara Braconi, MD, Ph.D. of the University of Glasgow, and Laura Goff, MD, MSCI, MMHC of Vanderbilt-Ingram Cancer Center. Three posters were selected for recognition awards:

• The 1st Special Abstract Prize was awarded to Matt Cooley, Mayo Clinic Graduate School of Biomedical Sciences for his abstract titled, “Methylated DNA Markers for the Diagnosis of Cholangiocarcinoma.”
• The 2nd Special Abstract Prize is awarded to Younghun Han, Dartmouth Geisel School of Medicine, Lebanon, NH, USA for his abstract titled, “The Genetic Landscape of Cholangiocarcinoma.”
• The 3rd Special Abstract Prize poster is awarded to Lara Heij, University Hospital RWTH Aachen, for her abstract titled, “Nerve Fibers in the Tumor Microenvironment as a novel biomarker for oncological outcome in patients undergoing surgery.”

“Drs. Cooley, Han, and Heij have demonstrated an unwavering commitment to the cholangiocarcinoma community. We are grateful to them for their dedication to the study of this difficult-to-treat disease. It is my honor to present the 2023 Poster Awards to these outstanding individuals,” said Stacie Lindsey, Foundation CEO, and founder.
The Foundation is the leading global resource for cholangiocarcinoma, a rare cancer of the bile ducts. The annual conference continues to be a premier source for the presentation of new and relevant research, innovative therapies, and patient education in cholangiocarcinoma.

More than 1,000 people are expected to participate in the 2023 annual conference including patients, caregivers, clinicians, researchers, industry representatives, and sponsors hailing from across the world.

The Foundation offers an opportunity for professionals in industry and medical fields consistent with the organization’s mission “to find a cure and improve the quality of life for cholangiocarcinoma patients,” to present a poster each year at the conference. Posters are intended to provide authors and conference participants with the opportunity to connect with one another and build upon the foundation of knowledge exchange and collaboration.